Vanderbilt University
Nashville, Tennessee, 37232, United States
NCT Number: NCT01344668
The primary hypotheses are that the intervention will improve A1C, blood pressure, lipids, weight, self-efficacy, self-management behaviors, and use of clinical services at 12 and 24 months follow-up.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Nashville, Tennessee, 37232, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Provide enhanced diabetes education
Provide Standard Diabetes Education
Time frame: 12 months
The primary outcome will be the improvement in A1C at 12 months between Intervention group patients and Control group patients.
Vanderbilt University
Other
Acronym: PRIDE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04639414
Diabetes Mellitus, Diabetes Mellitus, Type 2
Graz, Austria
View Trial DetailsNCT04734015
Diabetes Mellitus, Diabetes Mellitus, Type 2
Duluth, Minnesota, United States
View Trial DetailsNCT05648383
Body Weight, Cardiovascular Diseases
Tirana, Rruga E Dibrës, Albania
View Trial DetailsNCT07587151
Diabetes Mellitus, Diabetes Mellitus, Type 2
Rockford, Illinois, United States
View Trial Details